p38 inhibitor enhances growth inhibition and death in gallic acid-treated endothelial cells

International Journal of Molecular Medicine

Volumn 26, Issue 2, 2010, Pages 295-300

  Yang, Yeon Mi ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Cell death; Endothelial cells; Gallic acid; p38; Reactive oxygen species

Indexed keywords

GALLIC ACID; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; REACTIVE OXYGEN METABOLITE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALF (BOVINE); CELL COUNT; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; UMBILICAL VEIN; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINAE; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; FLOW CYTOMETRY; METABOLISM;

ANIMALS; CATTLE; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FLOW CYTOMETRY; GALLIC ACID; GLUTATHIONE; HUMANS; IMIDAZOLES; MEMBRANE POTENTIAL, MITOCHONDRIAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; REACTIVE OXYGEN SPECIES;

EID: 77955754350     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000465     Document Type: Article

References (29)

1. Niemetz R and Gross GG: Enzymology of gallotannin and ellagitannin biosynthesis. Phytochemistry 66: 2001-2011, 2005.
2. Shahrzad S, Aoyagi K, Winter A, Koyama A and Bitsch I: Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 131: 1207-1210, 2001. (Pubitemid 32275101)
3. Kang MS, Oh JS, Kang IC, Hong SJ and Choi CH: Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J Microbiol 46: 744-750, 2008.
4. Kratz JM, Andrighetti-Frohner CR, Leal PC, Nunes RJ, Yunes RA, Trybala E, Bergstrom T, Barardi CR and Simoes CM: Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol Pharm Bull 31: 903-907, 2008.
5. Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 91: 123-131, 2006.
6. Kaur M, Velmurugan B, Rajamanickam S, Agarwal R and Agarwal C: Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice. Pharm Res 26: 2133-2140, 2009.
7. Kawada M, Ohno Y, Ri Y, et al: Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 12: 847-852, 2001.
8. Ohno Y, Fukuda K, Takemura G, et al: Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 10: 845-851, 1999. (Pubitemid 30011832)
9. Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, Kato H and Kuwano H: Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 30: 605-613, 2007.
10. Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK, Hsieh YC, Chen CC and Yuan SS: Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anticancer activity in human prostate cancer cells. Cancer Lett 286: 161-171, 2009.
11. Inoue M, Sakaguchi N, Isuzugawa K, Tani H and Ogihara Y: Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull 23: 1153-1157, 2000.
12. Strlic M, Radovic T, Kolar J and Pihlar B: Anti- and pro-oxidative properties of gallic acid in fenton-type systems. J Agric Food Chem 50: 6313-6317, 2002.
13. Sakagami H and Satoh K: Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res 17: 221-224, 1997. (Pubitemid 27116670)
14. Blenis J: Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889-5892, 1993.
15. Repicky A, Jantova S and Cipak L: Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leukemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. Cancer Lett 277: 55-63, 2009.
16. Chowdhury R, Chowdhury S, Roychoudhury P, Mandal C and Chaudhuri K: Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation. Apoptosis 14: 108-123, 2009.
17. Deng YT, Huang HC and Lin JK: Rotenone induces apoptosis in MCF-7 human breast cancer cell-mediated ROS through JNK and p38 signaling. Mol Carcinog 49: 141-151, 2009.
18. Croons V, Martinet W, Herman AG, Timmermans J and De Meyer GR: The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 329: 856-864, 2009.
19. Han YH, Moon HJ, You BR, Kim SZ, Kim SH and Park WH: JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells. Int J Mol Med 24: 717-722, 2009.
20. Bassenge E: Endothelial function in different organs. Prog Cardiovasc Dis 39: 209-228, 1996.
21. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK and Lee YY: Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21 and apoptosis. Cancer Res 60: 3065-3071, 2000.
22. Han YH, Kim SZ, Kim SH and Park WH: Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 293: F511-F520, 2007.
23. Han YH, Kim SH, Kim SZ and Park WH: Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33: 1099-1105, 2008.
24. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y and Yabu Y: Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun 204: 898-904, 1994.
25. Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, Ogihara Y, Jiang BY and Chen Y: Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull 18: 1526-1530, 1995.
26. Isuzugawa K, Inoue M and Ogihara Y: Catalase contents in cells determine sensitivity to the apoptosis inducer gallic acid. Biol Pharm Bull 24: 1022-1026, 2001. (Pubitemid 32894122)
27. Serrano A, Palacios C, Roy G, Cespon C, Villar ML, Nocito M and Gonzalez-Porque P: Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 350: 49-54, 1998.
28. Poot M, Teubert H, Rabinovitch PS and Kavanagh TJ: De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol 163: 555-560, 1995.
29. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG and Nussler AK: Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89: 1440-1447, 2000.